ValiRx PLC
LSE:VAL
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
ValiRx PLC
LSE:VAL
|
UK |
|
Shiseido Co Ltd
TSE:4911
|
JP |
|
Heiwado Co Ltd
TSE:8276
|
JP |
|
Geron Corp
NASDAQ:GERN
|
US |
|
Parks! America Inc
OTC:PRKA
|
US |
|
T Rowe Price Group Inc
NASDAQ:TROW
|
US |
|
Meera Industries Ltd
BSE:540519
|
IN |
|
SFS Group AG
SIX:SFSN
|
CH |
Relative Value
The Relative Value of one
VAL
stock under the Base Case scenario is
hidden
GBX.
Compared to the current market price of 0.295 GBX,
ValiRx PLC
is
hidden
.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Multiples Across Competitors
VAL Competitors Multiples
ValiRx PLC Competitors
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| UK |
|
ValiRx PLC
LSE:VAL
|
2.2m GBP | 44 | -1.2 | -0.9 | -0.8 | |
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD | 33 690 872.8 | -160 127.7 | -194 446.1 | -192 227.3 | |
| US |
|
Abbvie Inc
NYSE:ABBV
|
362.8B USD | 5.9 | 86.7 | 14.4 | 20 | |
| US |
|
Amgen Inc
NASDAQ:AMGN
|
187.8B USD | 5.1 | 24.3 | 14.1 | 14.1 | |
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
171.4B USD | 5.8 | 20.2 | 12.6 | 15.6 | |
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
113.9B USD | 9.5 | 28.8 | 21.7 | 22.6 | |
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR | 2 091 | -533.6 | -581 | -565.5 | |
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
78.4B USD | 5.5 | 17.4 | 12.8 | 14.6 | |
| AU |
|
CSL Ltd
ASX:CSL
|
67.2B AUD | 3.1 | 34.4 | 11.4 | 14.3 | |
| US |
S
|
Seagen Inc
F:SGT
|
39.3B EUR | 20.1 | -61.8 | -66.6 | -60.1 | |
| NL |
|
argenx SE
XBRU:ARGX
|
36B EUR | 10.1 | 32.5 | 35 | 35.7 |